1. Executive Summary

2. United States Diabetes Population (2011 – 2022): An Analysis
2.1 Overall Diabetes Population
2.1.1 Type 1 Diabetes
2.1.2 Type 2 Diabetes
2.1.3 Newly Diagnosed Type 1 Diabetes

3. United States Insulin Delivery Devices Users Analysis (2011 –  2022)
3.1 Overall Insulin Delivery Users Snapshot
3.2 Insulin Pump Users
3.2.1 Type 1 Diabetes Insulin Pump Users
3.2.2 Type 2 Diabetes Insulin Pump Users
3.3 Insulin Pen Users
3.3.1 Reusable (Cartridge) Insulin Pen Users
3.3.2 Prefilled (Disposable) Insulin Pen Users
3.4 Insulin Pen Segment – (Reusable & Prefilled Insulin Pen) Users Share

4. Market Size & Analysis: United States Insulin Delivery Devices (2011 – 2022)
4.1 Overall Insulin Delivery Devices:  Market Snapshot
4.2 Insulin Delivery Devices Segment – (Insulin Pump & Insulin Pen) Market Share
4.3 Insulin Pump Market Size
4.4 Insulin Pen Market Size
4.4.1 Reusable (Cartridge) Insulin Pen Market
4.4.2 Prefilled (Disposable) Insulin Pen Market
4.5 Insulin Pen Segment – (Reusable & Prefilled Insulin Pen) Market Share

5. Key Drivers and Inhibitors of the United States Insulin Delivery Devices Market
5.1 Market Drivers
5.2 Inhibitors

6. United States Insulin Pump Preferred Brand – By Product
6.1 Pediatric
6.2 Adult

7. United States Insulin Delivery Devices Reimbursement Scenario
7.1 Insulin Pump
7.2 Insulin Pen

8. Key Companies Analysis

8.1.1 Medtronic
8.1.2 Insulin Pump – Product Portfolios
8.1.3 Medtronic – United States Diabetes Sales Analysis & Forecast (2013 – 2022)
8.1.4 Insulin Pump – Latest Development & Trends
8.2 Tandem Diabetes Care
8.2.1 Business Overview
8.2.2 Insulin Pump – Product Portfolios
8.2.3 Tandem Diabetes Care – Insulin Pump Sales Analysis & Forecast (2013 – 2022)
8.2.4 Insulin Pump – Latest Development & Trends
8.3 Insulet Corporation
8.3.1 Business Overview
8.3.2 Insulin Pump – Product Portfolios
8.3.3 Insulet Corporation – Insulin Pump Sales Analysis & Forecast (2011 – 2022)
8.3.4 Insulin Pump – Latest Development & Trends
8.4 Roche
8.4.1 Business Overview
8.4.2 Insulin Pump – Product Portfolios
8.4.3 Roche – North America Diabetes Sales Analysis & Forecast (2011 – 2022)
8.4.4 Insulin Pump – Latest Development & Trends
8.5 Novo Nordisk
8.5.1 Business Overview
8.5.2 Insulin Pen – Product Portfolios
8.5.3 Insulin Pen – Latest Development & Trends
8.6 Eli Lilly
8.6.1 Business Overview
8.6.2 Insulin Pen – Product Portfolios
8.6.3 Insulin Pen – Latest Development & Trends
8.7 Sanofi
8.7.1 Business Overview
8.7.2 Insulin Pen – Product Portfolios
8.8 Owen Mumford
8.8.1 Business Overview
8.8.2 Insulin Pen – Product Portfolios


List of Tables

Table 3–1: United States – Insulin Pen Users Share(Percent),2011 – 2016
Table 3–2: United States – Forecast for Insulin Pen Users Share(Percent),2017 – 2022
Table 4–1: United States – Insulin Pen Market Share(Percent),2011 – 2016
Table 4–2: United States – Forecast for Insulin Pen Market Share(Percent),2017 – 2022
Table 4–1: Worldwide – Healthcare Spending on Diabetes (Billion US$), 2015 & 2040

List of Figures

Figure 2–1: United States – Overall Diabetes Population (Thousand), 2011 – 2016
Figure 2–2: United States – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022
Figure 2–3: United States – Type 1 Diabetes Population (Thousand), 2011 – 2016
Figure 2–4: United States – Forecast for Type 1 Diabetes Population (Thousand), 2017 – 2022
Figure 2–5: United States – Type 2 Diabetes Population (Thousand), 2011 – 2016
Figure 2–6: United States – Forecast for Type 2 Diabetes Population (Thousand), 2017 – 2022
Figure 2–7: United States – Newly Diagnosed Type 1 Diabetes Population (Number), 2011 – 2016
Figure 2–8: United States – Forecast for Newly Diagnosed Type 1 Diabetes Population (Number), 2017 – 2022
Figure 3–1: United States – Overall Insulin Delivery Users(Thousand),2011 – 2016
Figure 3–2: United States – Overall Insulin Delivery Users Forecast(Thousand),2017 – 2022
Figure 3–3: United States – Insulin Pump Users (Number), 2011 – 2016
Figure 3–4: United States – Forecast for Insulin Pump Users (Number), 2017 – 2022
Figure 3–5: United States – Type 1 Diabetes Insulin Pump Users (Number), 2011 – 2016
Figure 3–6: United States – Forecast for Type 1 Diabetes Insulin Pump Users (Number), 2017 – 2022
Figure 3–7: United States – Type 2 Diabetes Insulin Pump Users (Number), 2011 – 2016
Figure 3–8: United States – Forecast for Type 2 Diabetes Insulin Pump Users (Number), 2017 – 2022
Figure 3–9: United States – Overall Insulin Pen Users (Thousand), 2011 – 2016
Figure 3–10: United States – Forecast for Overall Insulin Pen Users (Thousand), 2017 – 2022
Figure 3–11: United States – Reusable Insulin Pen Users (Thousand), 2011 – 2016
Figure 3–12: United States – Forecast for Reusable Insulin Pen Users (Thousand), 2017 – 2022
Figure 3–13: United States – Prefilled Insulin Pen Users (Thousand), 2011 – 2016
Figure 3–14: United States – Forecast for Prefilled Insulin Pen Users (Thousand), 2017 – 2022
Figure 4–1: United States – Overall Insulin Delivery Devices (Million US$),2011 – 2016
Figure 4–2: United States – Overall Insulin Delivery Devices Forecast (Million US$),2017 – 2022
Figure 4–3: Insulin Delivery Devices Segment Market Share(Percent),2011 – 2016
Figure 4–4: Insulin Delivery Devices Segment Market Share Forecast (Percent),2017 – 2022
Figure 4–5: United States – Insulin Pump Market (Million US$), 2011 – 2016
Figure 4–6: United States – Forecast for Insulin Pump Market (Million US$), 2017 – 2022
Figure 4–7: United States – Insulin Pen Market (Million US$), 2011 – 2016
Figure 4–8: United States – Forecast for Insulin Pen Market (Million US$), 2017 – 2022
Figure 4–9: United States – Reusable Insulin Pen Market (Million US$), 2011 – 2016
Figure 4–10: United States – Forecast for Reusable Insulin Pen Market (Million US$), 2017 – 2022
Figure 4–11: United States – Prefilled Insulin Pen Market (Million US$), 2011 – 2016
Figure 4–12: United States – Forecast for Prefilled Insulin Pen Market (Million US$), 2017 – 2022
Figure 6–1: United States –  Pediatric Insulin Pump Preference by Product(Percent),2016
Figure 6–2: United States –  Adult Insulin Pump Preference by Product(Percent),2016
Figure 8–1: Medtronic – United States Diabetes Sales Analysis (Million US$),2013 – 2016
Figure 8–2: Medtronic – Forecast for United States Diabetes Sales Analysis (Million US$),2017 – 2022
Figure 8–3: Tandem Diabetes Care – Insulin Pump Sales Analysis (Million US$),2013 – 2016
Figure 8–4: Tandem Diabetes Care – Forecast for Insulin Pump Sales Analysis (Million US$),2017 – 2022
Figure 8–5: Insulet Corporation – Insulin Pump Sales Analysis (Million US$),2011 – 2016
Figure 8–6: Insulet Corporation – Forecast for Insulin Pump Sales Analysis (Million US$),2017 – 2022
Figure 8–7: Roche – North America Diabetes Sales Analysis (Million US$),2011 – 2016
Figure 8–8: Roche – Forecast for North America Diabetes Sales Analysis (Million US$),2017 – 2022